The Shark Tank Several entrepreneurs in India created innovative solutions in the health tech field for the Indian market. Spandan and Janitri are two of them.
The healthcare sector in India has evolved significantly over the years, but it remains underserved. However, during the first and second seasons of Shark Tank India, some entrepreneurs developed innovative health-tech solutions to satisfy the needs of the Indian market.
Spandan and Janitri are two of them. Spandan manufactures pocket-sized ECG gadgets that assist heart patients and even detect cases of potential cardiac problems. Janitri, on the other hand, manufactures medical-grade foetal and maternal monitoring devices.
In a recent post on the professional networking platform LinkedIn, investor Namita Thapar, who invested in both start-ups, provided an update on their progress. “Today I met with two incredible Shark Tank founders at our Emcure office in Mumbai,” she wrote. Season 1’s Rajat Jain with the portable ECG equipment and Season 2’s Arun Aggarwal with the gadget for high-risk pregnancy. Both have increased their monthly sales from 10 lakhs to 50 lakhs, which is just the beginning of what looks to be a fantastic and impactful journey!”
Spandan and Janitri were founded by Jain and Aggarwal, respectively. She also described how Janitri rushed to the aid of several tourists at Kedarnath.
“I promised them Emcure networks, and today they met with our Emcure senior leaders to discuss additional ways to assist them in scaling through these connections.” The discourse was more inspiring because of their strong sense of purpose! Rajat collaborated with Emcure on a detection camp in Kedarnath last year that drastically reduced cardiac events, and he has bigger ambitions for this year’s camp. When Arun talks about his desire to reduce maternal mortality rates, his eyes light up. It is an honour to be a part of the journey of such young and driven founders!” She elaborated.
Spandan won an all-sharks deal worth Rs 1 crore in the inaugural season of the Indian business reality TV show. Furthermore, the company’s revenue increased by 40x after the show aired. Thapar, who is also the Executive Director of Pune-based Emcure Pharmaceuticals, spent Rs 1 crore in Janitri for a 2.5 percent stake in season two of the reality program, which aired earlier this year.
